AIDX
20/20 Biolabs, Inc.
Sector: Services-Testing LaboratoriesIndustry: Medical - Care FacilitiesCountry: USExchange: Nasdaq
Mkt Cap:
Float & O/S:
Inst Own:
DilutionScan read 20 of 20/20 Biolabs, Inc.'s SEC filings and found 8 warrant series, 11 convertibles, 1 equity line, 2 S-1 registrations and 6 completed offerings on file for AIDX. The latest dilution event on file is an offering on Jun 16, 2026. Analysis updated Oct 6, 2026.